Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone injection for severe cancer pain
NCT00626600Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone in cancer pain, sponsored by Mundipharma. Started May 2008; status: terminated.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00626600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626600.